Acute Pain
Volume 9, Issue 4 , Pages 183-192 , December 2007

Safety and efficacy of intranasal ketamine for acute postoperative pain

  • Kyle Christensen

      Affiliations

    • Wasatch Oral Surgery, 1268 West South Jordan Parkway, South Jordan, UT 84095, United States
    • ,
  • Elizabeth Rogers

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • ,
  • Geoff A. Green

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • ,
  • Douglas A. Hamilton

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • ,
  • Fred Mermelstein

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • ,
  • Edward Liao

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • ,
  • Curtis Wright

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • ,
  • Daniel B. Carr

      Affiliations

    • Javelin Pharmaceuticals, Inc., 125 CambridgePark Drive, Cambridge, MA 02140, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 349 4515; fax: +1 617 349 4505.

Received 7 March 2007 ,Revised 21 August 2007 ,Accepted 25 September 2007.

References 

  1. Marshall BE, Longnecker DE. General anesthetics. In: 9th Ed..  Hardman JG,  Limbird LE,  Molinoff PB,  Ruddon RW,  Goodman Gilman A editor. Goodman and Gilman's the pharmacological basis of therapeutics. vol. 1752:New York: McGraw-Hill; 1996;p. 307–330
  2. White PF, Way WL, Trevor AJ. Ketamine—its pharmacology and therapeutic uses. Anesthesiology. 1982;56:119–136
  3. Tucker AP, Kim YI, Nadeson R, Goodchild CS. Investigation of the potentiation of the analgesics effects of fentanyl by ketamine in humans: a double-blinded, randomized, placebo controlled crossover study of experimental pain. Anesthesiology. 2005;5:2
  4. Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain. 2004;108:17–27
  5. Diaz JH. Intranasal ketamine preinduction of paediatric outpatients. Paediatr Anaesth. 1997;7(4):273–278
  6. Kulbe J. The use of ketamine nasal spray for short-term analgesia. Home Health Nurse. 1998;16(6):367–370
  7. Malinovsky JM, Servin F, Cozian A, Lepage JU, Pinaud M. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children.. Br J Anaesth. 1996;77(2):203–207
  8. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacol. 2006;60:341–348
  9. Silbert BS, Osgood PF, Carr DB. Burn pain. In:  Yaksh TL,  Lynch C,  Zapol WM,  Maze M,  Biebuyck JF,  Saidman LJ editor. Anesthesia: Biologic Foundations. Philadelphia: Lippincott-Raven Publishers; 1998;p. 759–773
  10. Sheckler MT, Mermelstein F, Hamilton DA, Carr D. Nasal delivery of analgesics. ONDrug Deliv. 2005;17–19
  11. Chien YW, Su KSE, Chang SF. Chapter 1: Anatomy and physiology of the nose. In:  Swarbrick J editors. Nasal systemic drug delivery. New York: Marcel Dekker; 1989;p. 1–26
  12. Cooper SA, Beaver WT. A model to evaluate mild analgesics in oral surgery outpatients. Clin Pharmacol Ther. 1976;20:241–250
  13. Forbes JA. Oral surgery. In:  Max MB,  Portenoy RK,  Laska EM editor. The design of analgesic trials. Advances in pain research and therapy. 18:New York: Raven; 1991;p. 347–374
  14. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347–354
  15. Weg S, 1998, personal communication.
  16. Wermeling DP, Miller JL, Rudy AC. Systemic intranasal drug delivery: concepts and applications. Drug Deliv Technol. 2002;2:56–61
  17. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB. What decline in pain intensity is meaningful to patients with acute pain?. Pain. 2003;105:151–157
  18. Beecher HJ. The powerful placebo. JAMA. 1955;159:1602–1606
  19. Mistry RB, Nahata MC. Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy. 2005;25:1104–1111
  20. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology. 1998;88:82–88
  21. Schley M, Topfner S, Wiech K, Schaller HE, Konrad CJ, Schmelz M, et al. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees. Eur J Pain. 2007;11:299–308
  22. Visser EJ. Chronic post-surgical pain: epidemiology and clinical implications for acute pain management. Acute Pain. 2006;8:73–81

PII: S1366-0071(07)00167-2

doi: 10.1016/j.acpain.2007.09.001

Acute Pain
Volume 9, Issue 4 , Pages 183-192 , December 2007

Article Tools

* Image Usage & Resolution